Jiesi Luo

biography

Jiesi Luo earned B.S. from China Agricultural University, China and Ph.D. from Michigan State University, USA, and currently works as postdoctoral associate in School of Medicine at Yale University. Dr. Luo has gained the 9-year experience on stem cell biology for regenerative medicine, especially that for the therapies on cardiovascular diseases. His studies was initiatedfrom establishing the large animal (canine) preclinical model of induced pluripotent stem cell (iPSC) based therapy for human, via generating canine iPSC model and elucidating the regulatory mechanism for pluripotency maintenance of canine iPSCs. After joining in Yale University, Dr. Luo focused on multiple fields related to the application of iPSC-based therapy for cardiovascular diseases and associated molecular mechanisms, including construction of human iPSC-based engineered vessel graft, genetic disease modeling by using human iPSC-derived smooth muscle cells, as well as generation and cardiovascular differentiation of iPSCs for pre-clinical large animal model.